Bright Minds Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$7,372,225 over the previous period. Total operating expenses were $7,214,933.

Profit Margin

Bright Minds Biosciences Inc. (NASDAQ:DRUG): Profit margin
2019 0 -78.71K
2020 0 -485.94K
2021 0 -8.51M
2022 0 -15.18M
2023 0 -7.37M

DRUG Income Statement (2019 – 2023)

2023 2022 2021 2020 2019
Revenue
Revenue
00000
Cost of revenue
72.45K6.03K000
Gross profit
-72.45K-6.03K000
Operating exp.
Research and development
4.99M12.18M6.31M354.85K42.00K
Selling and marketing
119.41K551.86K852.15K9.61K36.59K
Total operating expenses
7.21M14.73M8.60M469.35K78.71K
Operating income
-7.21M-14.74M-8.75M-469.35K-78.72K
Other income (expenses), net
-157.29K-222.77K107.79K-5.45K3
Income before tax
-7.37M-14.96M-8.65M-480.37K-78.71K
Income tax expense
0222.77K-135.43K5.56K-236
Net income
-7.37M-15.18M-8.51M-485.94K-78.71K
Earnings per share
Basic EPS
-1.98-6.15-4.74-0.38-0.06
Diluted EPS
-1.98-6.15-4.74-0.38-0.06
Data sourceData sourceData source